Good day, everyone, and welcome to Integra's 3rd Quarter 2019 Earnings Release Call. Today's call is being recorded. It this time, for opening remarks and introductions, I would like to turn the call over to Bill Seymour, Integra's Vice President of Investor Relations. Please go ahead, sir.
Good morning, everyone. Earlier today, we announced the financial results for our third quarter of 2019. Before we begin, I would like to remind listeners that our comments today will include some forward looking statements. These statements involve a number of risks and uncertainties and actual results could differ materially from those projected in the forward looking statements. Additional information regarding These risks and uncertainties are contained in our most recent annual report and subsequent quarterly reports that we have filed with the SEC.
Please refer to the information on the disclaimer slide in the presentation. On this call, we will also refer to non GAAP financial measures as defined by and Regulation G, you can find a reconciliation table on today's press release, as well as on the Investor Relations page of our website at integral.com. On the call today are Bertrand Loy, our CEO and Greg Graves, our CFO, I'll hand it over to Bertrand.
Thank you, Peter. I will make some comments on our third quarter performance. How we see the industry environment and discuss our expectations for the balance of the year. Greg will follow with more details on our financial results, and our guidance for the 4th with many positives, but also a few things that were below our expectations. On the positive side, sales in the third quarter grew sequentially, both as reported and also on an organic basis.
Driving that top line growth was strong momentum with our advanced solutions in new nodes in logic and foundry, as we anticipated. This growth was particularly highlighted by good performance in our microcontamination control and advanced materials Handling division. In our second quarter call, we said that our CapEx driven products had improved all the patents, and this resulted as expected in sales that were up significantly sequentially in Q3 for products such as Foods gas filters and gas purifiers. Good expense control was also evident during the quarter, driven by disciplined execution and the benefits of the recently announced reorganization. All of this translated into improved profitability with sales which represented a sequential increase of 13%.
On the other hand, the performance of our SCM division was below our expectations for the quarter. This was the result of temporary supply constraints in our specialty coatings and specialty gas businesses and the timing of shipments in our graphite business. We believe these operational issues are largely behind us and expect SCM to end the year on a high note. Finally, gross margin was lower than expected for the third quarter. We expect gross margins to improve in Q4 and Greg will provide more perspective on this shortly.
Let me now cover our view on the industry Logic and Foundry continued to be solid, driven by favorable seasonal demand, near normal utilization rates and the positive impact of key new technology node transitions. On the other hand, However, while mix signals persisted, the overall memory market appears to be stabilizing and in some cases improving particularly in the NAND in Q3. Overall, our performance in the third quarter was solid I am proud of our team's ability to deliver these results in light of the significant organizational changes we implemented during the quarter and in the midst of continued industry softness. Trades that our unit driven business model is highly resilient and very differentiated. As we are currently seeing in the recent technology node transitions, greater materials, intensive and greater materials purity will be the 2 defining factors of the next generation of semiconductor performance.
And as you know, Entegris operates at the Crossroads of Materials intensity and materials purity. In other words, we have never been better positioned and more relevant for our customers to help them achieve the targeted levels of chip performance, yields and reliability. For the past 6 years, we have allocated more than $3,000,000,000 of capital. Acquisitions have historically been the largest area of capital allocation of our growth and a way to broaden our technology and product portfolio. To that end, since the beginning of the year we acquired DSC and NPD, which significantly enhanced our capabilities in advanced deposition materials.
And last month, we acquired A Now, a filtration company for Semiconductor And Other Microelectronics And Life Sciences Applications. PNL is located in Guangzhou, China and will be part of our microcontamination division. The addition of A Now not only brings new membrane technology and liquid filtration offerings to integrate global portfolio, but also provides integrase with manufacturing capabilities in China. Looking ahead to the fourth quarter, our guidance for the fourth quarter is based on the strength of our business and As we discussed last quarter, of several important node transitions, which are driving the adoption of many of our process solutions. Greg will discuss these drivers in more detail shortly.
In closing, I am pleased with our overall results in the third quarter, our business is starting to show the recovery and momentum we anticipated And we expect to close out 2019 with strong performance in the fourth quarter, and we are set up well going to 2020. I will now turn the call to Greg for the financial results. Greg?
Thank you, Bertrand. Our 3rd quarter performance was solid. Q3 sales of $394,000,000 worth in line with our Sales were up 4% sequentially on a reported basis and were up 2% on an organic basis. Q3 GAAP diluted earnings per share were $0.30, down 12% year over year and down 67% sequentially. As Q2 included the proceeds associated with the terminated Versum transaction.
On a non GAAP basis, EPS of $0.50 was up 9% year over year and up 28% sequentially. A more favorable and expected non GAAP tax rate related to discrete items contributed approximately $0.05 to EPS in Q3. Moving on to gross margins, GAAP gross margin $5,000,000 from an inventory write up associated with the recent acquisitions and restructuring costs. Non GAAP gross margin was 40 was lower than expected, primarily driven by higher manufacturing costs and unfavorable mix. We expect gross margin we expect gross margins to approach GAAP operating expenses were $118,000,000 included a total of approximately $31,000,000 from amortization of intangible assets restructuring costs, integration costs, and transaction fees associated with the MPD and a now transaction.
Non GAAP operating expenses in primarily by effective expense control and the impact We expect non GAAP operating expenses will be $90,000,000 Last quarter, we announced the strategic organizational realignment aimed at increasing our customer responsiveness. We realized the modest amount of savings from these changes in Q3. We expect to be at the full 20,000,000 annual savings run rate by the end of the year. Q3 GAAP operating income was 53,000,000 dollars or 13.4 percent of revenue and non GAAP operating income was $88,000,000 or 22.4 percent of revenue. Our GAAP tax rate was 2.1 percent for the third quarter and included a $5,000,000 discrete benefit related to R and D credits and updated tax reform guidance.
We expect our full year 2019 GAAP tax rate to be approximately 20%. Our non GAAP tax rate was 12%. The non GAAP rate benefited from the same discrete items mentioned with regard to the GAAP rate. Expect our full year non GAAP tax rate will of approximately 21%. Adjusted EBITDA for the quarter was approximately 108000000 or 27 percent of revenue.
Turning to our performance by division. Q3 sales of 128,000,000 specialty chemicals and engineered materials, or FCEM, were down 3% from a year ago and up slightly sequentially. The year over year decline was primarily driven by the Specialty Materials business. This decline was partially offset by the positive impact the DSC and MPD acquisition. Adjusted operating margin for SCEM was below our expectations at 18.6%.
The decline in operating margin was driven primarily by lower capacity utilization and unfavorable product mix. Despite the Q3 performance, we remain optimistic about SCEM's business. During the fourth quarter, we expect to see a significant improvement in the Specialty Materials business and an increase in deposition materials as a result the impact of for microcontamination control, or MC, were up 3% from last year and up 4% sequentially on both a reported and organic basis. The year on year sales increase in the quarter was driven by strong growth in liquid filtration for photoresist and in our bulk gas purification systems. Adjusted operating margin for MC was 31.9 that.
The year over year increase was driven by volume growth and effective expense control. Moving to the 4th quarter, We expect the positive momentum of MC will continue driven by strong sales of liquid filtration to enable the new process node. Q3 sales for Advanced Materials Handling or AMH of $117,000,000 was down from last year but was up 9% sequentially. The year over year decline in sales was primarily driven by softness in capital driven business. The sequential increase in AMH sales was driven by a recovery of some of those same CapEx businesses, including hoops, and particle sizing measurement tools, a business we acquired last year.
Adjusted operating margin for AMH 17.2 percent, down year over year, but up 300 basis points from Q2. The sequential improvement in AMH margins was primarily driven by the higher volume and effective expense control. Cash flow from operations for the 3rd The lower cash flow reflects higher primarily related to the Versum termination fee. 3rd quarter CapEx $26,000,000 We continue to expect to spend approximately $110,000,000 of CapEx in 2019 to support new product introductions improved technical capabilities and growth in our filtration and liquid packaging business. During Q3, 400,000 shares for $15,000,000 for an average price of $42 per share.
Turning to our outlook for Q4. We expect sales to range from $420,000,000 We expect $6 per share. In summary, we delivered improved performance in Q3 despite a muted industry environment and expect to
Thank
you.
You.
We'll now take our first question from Toshiya Hari from Goldman Sachs. Please go ahead. Your line is open.
Good morning,
guys. Thanks for taking the question. I had 2 one on your Q4 guide and the other on M And A broadly. In terms of the Q4 guide, Britani, you're obviously guiding, revenue up, I think 7% or 8% sequentially at the midpoint. Which is significantly above typical seasonality.
How much of this is M and A? Just as a reminder, how much of it is organic And then within organic, the organic component, you talked a little bit about the node transitions that, that contributes to growth. But Is there anything kind of one time embedded in the Q4 guide or when we think about modeling Q1 of 'twenty and beyond, is Q4 the new baseline? And then the second part of that first question, in terms of gross margins, Greg, you talked about higher manufacturing costs and mix being an issue in Q3, is the sequential improvement into Q4 essentially those 2 kind of abating or normalizing or is there more to it? Thanks.
And then I will let Greg answer the gross margin question. So to go back to the Q4 guidance, The midpoint represents an 8.5 percent of sequential growth. And the way you get there, first if you look at the industry and the assumptions that we have around the industry, it's a combination of wafer starts that we expect to see up modestly sequentially. Or down, I'm sorry, modestly sequentially. And we expect the industry CapEx to actually enjoy a pretty nice sequential rebound in the mid teens sequentially as a result of the uptake that we expect to see in logic and memory related spending.
So that's the industry backdrop, which is overall a blend of 2% up sequentially. So add to that about 100 basis points coming from ANAL. So ANAL is the Chinese filtration company that we acquired in Q3. And we expect them to contribute about $4,000,000 or a bit more than $4,000,000 in Q4. So the rest is really organic growth and that implies a 500 basis point organic growth in excess of the market.
And the strong performance will come from liquid filtration, deposition materials, specialty coatings, graphite platforms. So most of which are really linked, as you mentioned, to node transitions in advanced logic and advanced memory. So second part of your question is, well, is it the new normal I'm not sure we necessarily run rate that, that momentum, we like our momentum, but as you know, a lot of those, new node transitions that, we expect going into 2020, are still hard to forecast, both in terms of the timing of those transitions as well as the magnitude of those node transitions. So again, let's focus on Q4 for now. We like the momentum in Q4.
Think it bodes well for the future. And I will turn the mic to Greg to answer the question on gross margin. Yes.
So with regard gross margin, a couple of things. 1, we talked about Q3 being slightly short of our guidance and that was a function of mix and some manufacturing inefficiencies. As we move into Q4, the improvement is, really twofold that we don't expect much change in mix. The improvement is largely volume. And improved manufacturing efficiencies.
Got it. And then my second question on M And A, We're trying, you touched briefly on the A Now acquisition in your prepared remarks. But if you can kind of elaborate on that, perhaps the history that you guys have with the company and, what was unique about A now and the potential revenue synergies when you think about the combination over the next couple of years. And then, related to that, if you can touch on, the M and A pipeline going forward, clearly, M and A is becoming a a bigger percentage of your of your, you know, long term growth model, it seems like. How comfortable are you with the sustainability of M and A as you kind of look across your businesses over the next couple of Thank you.
Sure. So as you mentioned, Toshiya, acquisitions is certainly major part of our growth strategy. I believe that we've been very effective acquirers in the past. And our M and A pipeline remains rich and I believe actionable in many ways. So in other words, I think we would have opportunities to add to the already long list of small to midsized deals that we have been completing in 29 18 and then in 2019 with DSC NPD and A Now in Q3.
When it comes to A Now, this is a company we know well. It has been a long time supplier of certain types of membrane to Entegris. And we've been in discussion with A now for a number of years. So what we like about this acquisition is that it brings not only, complementary membrane technology, but also expands greatly the filtration portfolio that we already have at Entegris. And that's going to help us not only expand in China and capitalize on the strength of the Chinese market, but also access and help in our, expand their reach and expand our technical capabilities to, to access non Chinese market on a global scale.
So We are very excited to, to welcome our new colleagues to the Integris team. We have high expectation for this business. This is a business that today generates a little bit less than $20,000,000 annually, and we would expect that business to grow in the mid-20s on a CAGR basis for the years to come.
Thank you for the details.
We will now take our next question from Sidney Ho from Deutsche Bank.
Great. Thank you very much. I just want to follow-up with the previous question. I know Q4 guidance up 8% to 9% is pretty good. But it's not as much as your implied, guidance from the last quarter, especially given there's some upside from your large Taiwan customers.
And I think you just mentioned that Q3 will supply constrained in, I think, SCEM. Wonder if there's any offset here as compared to what you expected a quarter ago.
So Sydney, no, I think what we what we are, guiding to is very much consistent with what we had been describing. If you look at Q4 and you put that in the broader context of the full year performance, We are very much in line with the stated objective of outpacing the industry by 500 to 600 basis points. In 2019. And I think that that's really what the midpoint of that guidance would suggest, no, we we we feel good. As I said, we feel good about, the success of a number of new products that we introduced to the market this year, we feel good about the level of engagement with our advanced logic and advanced memory customers.
And frankly, I think that the guidance that we're providing for Q4 and for the full year, I think, is well ahead of our stated long term objectives of outpacing the industry by 200 to 300 basis points.
Okay, great. My follow-up to that is I think last quarter you expected industry MSI for this year to be down 3% to 4%. What are your thoughts now, I guess, for both MSI and the CapEx side of things? And do you have any preliminary thoughts on MSI for next year? And what are the moving parts that we should be paying attention to?
Yes. So I think that last time we spoke, we were, projecting MSI down in the mid single digits. I think right now we expect MSI down about 7% on a full year basis in 2019. And we expect CapEx to be down in the low teens, for 2019. And that's really what is behind our full year guidance for 2019.
It's too early for us. To quantify our views on on 2020. I think that there's certainly, a lot more optimism in the industry right now, a more positive tone around capital spending and production levels. But I think it's too early for you for us to to give you a guidance around 2020.
So just to be clear, the CapEx being down low teens is an improvement from what you thought before.
Yes.
Next question comes from Patrick Ho from Stifel.
Bertrand, maybe first is a big picture question in terms of the opportunity for your specialty chemicals and electronic materials business. As NAND goes to additional layers, how do you see the opportunity from a content perspective both, I guess, from an increase in layers as well as potentially new materials being used, how do you see that opportunity at the 3 d NAND industry moves to 128 layers and above?
So that certainly remains, one of the most attractive opportunities for us, both in terms of deposition materials, but also in terms of, ways of cleaning the wafers in between those deposition steps and, after the CMP process steps. So I think that we have many opportunities for us to, position our SCM portfolio on the technology road map of advanced memory makers and our teams have been very busy doing that for the last several years. So as we see more wafers produced at 96 and then 128 layers you should see an acceleration in the top line of our SCM platform.
Great. That's helpful. And maybe as my follow-up question, looking at the Advanced Foundry And Logic end, where there's also a lot more changes on the manufacturing front. There's also a lot more new materials being used in those manufacturing processes, how do you look at Advanced Logic in terms of the opportunities ahead, both from a a content perspective, also, and and new materials that are being used such as cobalt, materials from that front where, it hasn't been used previously. How do you see the opportunities from a big picture perspective?
I think that all of those opportunities are, again, very, very exciting. We have been consciously focused on some of those new materials, Cobalt, Retinium, and a few others. Waiting for those materials to be broadly adopted by the semiconductor industry, both in logic and memory. I think we are approaching that earning point. And I think that with the acquisition of DSC NPD and all of the investments that we have made internally, I think that we are really well positioned to support the adoption of those materials.
Many of those materials, by the way, will be solid materials. And, that comes with a number of challenges. And I think that At Entegris, we've been able to really develop some very unique solutions, leveraging the capabilities of our 3 divisions to, palletize those materials in a solid form, but also to develop a very unique delivery system that considerably made the solids before, the metal can be deposited onto the wafer. Purify, the gas on the outlet. So we have that very unique system approach that is leveraging all of the capabilities of the various business units that we have in our portfolio.
So again, I think we are very well positioned to support the adoption of the or the introduction of those new metals in, in the advanced chips. And we just cannot wait for that to be the case.
Great. And final question for me related to those two questions for Greg. In terms of R and D spending. I know R and D can be lumpy just because of the timing of certain projects But given a lot of these, changes and inflections in the, semiconductor manufacturing, process. How do you see R&D longer term?
Is there a need to kind of, I guess, elevate R and D to keep up with these or, do you feel very comfortable with the percentages you have today?
I mean, our targeted R and D spend is 8% of revenue over the long haul, Patrick, and we're a little bit light of that in the most recent quarter. But that's our intent now. But you're accurate.
I mean, we will need
to increase the spending over time, but at this point, our intent is to increase that really in line with the increases in revenue.
Great. Thank you very much.
We will now take our next question from Chris Kapsch from Loop Capital Markets.
Yeah. Good morning. So I'm juggling some conference calls this morning. So I apologize if you touched upon this already, but Obviously, there was a very sad news about TSMC's pretty dramatic CapEx increase and I guess pundance to sort of frame that up about being all about 5G, but my curiosity is, is that you've, Bertrand, you've talked about how impressed you were with the with TSMC's, ramp and yield improvement at 7 nanometers and that they're already starting to tape out 5 nanometer. So my question though to you is, is there any way to frame up the opportunity for Entegris as TSMC transitions and ramps to 5 nanometer node in terms of either the process of record wins that you've been able to achieve or if there's a way to think of it in terms of content per chipset, And just timing on, and which segments would benefit the most, from that transition.
Thank you.
So, Chris, we won't talk about customer specific opportunities. We've never done that. But I think if you look at our performance in Taiwan, I think that itself is a good proxy for, the magnitude of the opportunities that we have at certain customers on the island. I would only say that, a lot of the new architectures will drive the need for the adoption of new materials and new chemistries. Will also require greater levels of purity.
And all of that will actually render our value proposition increasingly important for all of the technology leaders. So I think we are really well positioned This is really what is behind, our long term commitment to outpace the industry by 200 to 300 basis points. So again, putting aside any customer specific consideration, the reason why we've been willing to make that very bold commitment to consistently outpace the industry is because we believe that there are a number of exciting opportunities in SCM infiltration and even in AMH at those advanced nodes, and I would leave it at that.
Fair enough. I appreciate the comments.
Our next question comes from David Silva from B. L.
Yeah. Hi. Thank you. I'll also preface my remarks by apologizing. I have had to jump around a little bit.
I'd like to maybe follow-up and broaden the last question, regarding TSMC, but during this earnings period, we've heard comments from other chip makers. Some of whom have cut their CapEx, some of whom have, forecast, sharp declines and revenues for the coming quarters. And of course, there were the comments from TSMC. And I'm just wondering, given your perspective on the industry, could you what might be the 1 or 2 key data points that you take away. So for instance, is this a directional divergence between, let's say, IDMs and, foundry memory versus logic.
And I'm also wondering if there is a divergence between maybe a more rapid adoption of the next node or the node transitions you've mentioned and maybe some diminution or erosion in the IoT demand from legacy nodes that I believe has been a pleasant surprise or pleasant tailwind to your business. And other suppliers over the last few years.
So I the way I would probably answer the question is to say that, 2019 has been a difficult year to navigate. The industry was choppy. You could see very uneven trends across many different segments. And I think you mentioned some of them with some muted levels of production in mainstream fabs some high level of activity on the leading edge, and an industry CapEx that was really playing yoyo throughout the year. And I think that This is why we are actually very proud of our performance in 2019.
I think that we've been able to demonstrate the resilience of our business model and the relative stability of our platform in what is still again a very challenging business environment in 2019. So, again, that bodes well for hopefully better years where most of those drivers been positive. And as I mentioned, I think that there are a lot of reasons for us to be excited about what's ahead of us on the technology roadmap of the advanced memory and advanced logic makers.
Okay. Thank you for that. And then just a quick I would like to follow-up maybe on the question earlier I believe, regarding your M and A pipeline. So you've noted that, your company has made a couple of niche acquisitions to support your efforts in advanced deposition materials. And you also mentioned that the pipeline remains rich.
And I'm just wondering, does advanced deposition materials remain a priority as you explore the pipeline of opportunities or is the strategy at this point to develop what's already in house. Thank you.
So if you, if you go back, you will see that, our capital allocation framework has been very transparent and very consistent over the last several years. And we have consistently highlighted, Filtration highlighted, materials and high purity packaging as areas of our portfolio where we would want to add to. So when it comes to deposition materials, I think that's one of the areas where you should expect us to continue to invest into. And we talked about the reasons behind that choice, but there are other, types of materials that could actually become of interest. To us.
And as I mentioned, I think that, the pipeline that we are looking at is a reflection of where we believe, there is value to be created and growth to be generated. And, you know, I think that, we've been pretty successful at, acquiring and integrating companies. I'm actually very pleased with the results of the various acquisitions that we completed over the last 2 years, and I certainly hope that we can add to that pipeline.
Thank you very much. Our next question
comes from Amanda
Scanese proximity.
Hi, thanks for taking the question. Just talking about sort of capacity, you had mentioned earlier that new capacity was coming on line earlier this year, with the expectation to add, you know, $4,000,000 to $5,000,000 in revenue, you know, this quarter and next quarter. Can you just talk about how that capacity is ramping up And is it still already fully committed or are you seeing anything different with regards to that?
Yes, Amanda. This is a good question and this is actually one of the operational setbacks that we faced in our SCM division in Q3. The capacity that we're expecting to bring online in Q3 had some startup issues and, and we're late. And we expect that capacity to come online within the next couple of weeks at this point. So we didn't have access to that capacity in Q3.
We expect to, to recover from that in Q4.
And so when that is fully ramped up, is it still about $5,000,000 a quarter at sort of max capacity, or is there an to kind of recover some of that, you know, that you would have spent in or would have received in the 3rd quarter?
Yes, given where we are in the quarter, I would say I'd expect probably 2 to 3 in, in Q4. But then you're right on a once the full capacity is online and we have the benefit of that of that on a full quarter expect that to be closer to 4 to 5 and we should be able to, to recover some of that business indeed.
Okay. And then can you
just remind us what your percentage of sales is to leading edge versus lagging edge and how that's changed over the last couple of quarters? Are you starting to see any more sort of new activity coming from the leading edge customers?
We don't track that very precisely. I mean, what we look at is really would be a revenue coming from new products and that number is about 30% roughly. It has come down a little bit this year simply as a reflection of the fact that, the activity levels in advanced memory was a bit lower in 2019 than 2018. But, I think we're seeing the inflection point and I think that, we expect new products to contribute back to about 30% in 2020 and beyond.
Okay. I think that was all I had. Thank you.
Thank you.
Our next question comes from Blake Keating from Seaport Global
Hi, good morning. This is Blake Heating on for Mike Harrison. You commented last quarter that visibility was getting better because forecasts were turning into orders. Is your visibility still improving such that you can kind of see that sustained recovery or should we expect a more uneven recovery over the next 3 to 4 quarters?
So that comment was really, done in the context of our CapEx business. And, we I believe that we have actually a pretty good visibility on that part of our business, which represents about 30%.
Alright. Thank you. And then
That's what yeah. Go ahead.
And then another question on M and A. Can you update us on how the integration process is going and maybe your confidence level and being able to leverage these additional capabilities. And then also, I kind of touched on it already. But are there still some regions of the world or capabilities where you could improve through acquisitions? And are there acquisitions currently in the pipeline that you're excited about?
That's a good question. So if you look at the acquisitions that we completed last year, is, so SAES Pure Gas and PSS, Both of those acquisitions are doing extremely well. Actually, both of those platforms generated record quarters in Q3. So very, very pleased with the performance of those businesses. DSC and NPD was still in the very early innings of that in integration.
And there is actually a lot of, a lot of the integration of NPD would have to do with how we integrate DSC, NPD, and our own, capability. So that's an integration plan that will we've completed by the middle of 2020. So it's a little bit too early frankly for us to comment on that, but the teams are very focused And we are obviously keeping a very, very close eye on that. So the second part of your question around, the regional footprint and our desire to to maybe strengthen our footprint or capability through M And A in certain regions. I think A Now is a perfect example of that.
We have been investing a lot in China. Obviously, we are we have invested in new sales offices in local partnerships. We announced an investment in a new tech center in Shanghai earlier this year. And A Now is just another option for us and that option is really around manufacturing not only filters, potentially later on, other types of integrase products in China to support our local, customers. And so actually, that's one of the many reasons why we are very excited about it now.
Thank you.
Our next question comes from Paretosh Misra from Berenberg.
Thank you. Good morning. In your CapEx driven business, how is the book to bill ratio versus what it looked like 3 months ago?
So it's still greater than than 1. And, So I mean, again, we have a fair amount of visibility on that part of the business. And, we expect that business to do pretty well in Q4 as well.
Got it. Got it. And then the second for this more like a housekeeping question, but in the acquisition that you did in Q3 and Jawa now, have you provided any revenue or EBIT expectations from that?
I just mentioned earlier that the current revenue is just short of $20,000,000 and that we're expecting that business to grow in the mid 20% on a CAGR basis over the next few years. We didn't comment on the profit profitability profile of business.
Got it. And apologies for missing that. And last one, sorry if you answered that one already too, but the $20,000,000 in cost savings that you, flagged in the previous earnings call, is that all come completely incorporated in your Q4 expectation or some of that might come in next year?
Yes. What we're saying is, by the end of Q4, we'll see the full benefit of that. So we saw You look at our OpEx in Q3 was slightly better than expected. Part of that was as a result of those cost savings. We'll see some additional parts of that in Q4 but we'll be at the full run rate as we enter Q1.
Thanks guys. That's all I had.
Our next question comes from Krish Sankar from Cowen And Company.
Hi, thanks for taking my question. I had 2 of them. Bertrand, if I look at your China revenues year to date. It's about $150,000,000 compared to the last year, year to date. There's about $145,000,000.
Outside of the impression China has been spending quite a lot. So I'm kind of curious why your China based revenues haven't grown more in line with Chinese CapEx. This is, you know, it seems to be more type of disconnect. Any color on that would be helpful, and I'll try to follow-up.
Yes. So if you look at our China business on a year to date basis, it's actually up 3% which I think is a good result given the fact that the level of CapEx in China this year in 2019 was significantly lower than last year. So And if you look at it on a sequential basis, our microcontamination business was up, our AMH business was up There were a couple of very customer specific situations for our SCM business to be down sequentially in China. But overall, you know, we feel pretty good about the, the level of activity and our performance in China given the industry context and the geopolitical context in 2019.
Got it. That's helpful, Bertrand. And then a final question on gross margin. You know, clearly foundry spending a lot right now. And at some point in the future, memory will recover.
Does your gross margin profile differ between selling to foundry and memory customers?
Actually, there's really not a much difference in margin between the two customer groups nor is there a difference in our margin really between unit driven products and CapEx driven products. I mean, in I would say, in really in all categories, we have products that are well above the corporate average, some that are below the corporate average obviously, but as it relates to any specific category, our margins are relatively similar.
Got you. Thanks, Greg. Thanks for the time.
Sure.
Our final question is a follow-up from Toshiya Hari from Goldman Sachs.
Yes, thanks so much for taking the follow-up. Bertrand, your North America business was up nicely, I think up 10% year to date. I think if you look at just the 3rd quarter, I think it was up
in the in sort of
the mid to high teens. Was, the node transition at, the leading edge, in logic kind of the key driver there on a year over year basis, or was there Was there more to it perhaps M and A? Thank you.
Yes, so right. So there's a couple of components. 1 is indeed the inclusion of MPD. In North America revenue. But then on an organic basis, a very significant growth in our microcontamination business.
And that's a function of many opportunities in, leading edge fabs as well as opportunities with chemical manufacturers supplying some of those leading edge nodes as well. So indirectly all related to leading edge. So but as you said, very, very pleasing to see the strength of North America sequentially and on a year to date basis.
Got it. Thank you so much.
That's our final question, operator. Thank you very much.
This concludes today's call. Thank you for your participation. You may now disconnect.
I'm gonna and didn't call him back.